AUTHENTIC INTELLIGENCE GLOBAL LTD

Company number 08367464 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment Report

Company: Authentic Intelligence Global Ltd (formerly Athena Defence Limited)
Company Number: 08367464
Status: Active — Private Limited Company
Accounts Category: Micro
Latest Accounts: Year ended 31 March 2026
SIC Code: 82990 — Other business support service activities not elsewhere classified


1. Financial Health Score: F — Critical

On a scale of A to F, where A indicates strong financial resilience and F indicates severe distress, the company is graded F.

The core reason is balance-sheet insolvency: total liabilities exceed total assets, and shareholders’ funds are negative. The company’s net assets fell from -£506 in 2025 to -£725 in 2026, meaning accumulated losses have wiped out the original £100 share capital and created a deficit. Short-term creditors have grown rapidly, while the asset base remains minimal. In short, the company owes significantly more than it owns, and it has almost no liquid buffer to meet obligations due within the next year.


2. Key Vital Signs

Vital Sign Latest Reading (2026) Prior Reading (2025) Interpretation
Net assets / Shareholders’ funds -£725 -£506 Balance-sheet insolvent; the company owes more than it owns.
Total current assets £929 £69 Minimal asset base; no fixed assets or long-term investments.
Total current liabilities £1,654 £575 Short-term obligations have nearly tripled in one year.
Current ratio ~0.56 ~0.12 Severe liquidity strain; well below the healthy benchmark of 1.0.
Working capital (net current assets) -£725 -£506 Negative working capital; no short-term cushion.
Share capital £100 £100 Nominal capital; losses far exceed subscribed capital.
Filing compliance Up to date Up to date Administrative “vitals” are stable; no overdue accounts or returns.

How to read the current ratio: A current ratio of 0.56 means the company holds roughly 56p in current assets (cash, debtors, etc.) for every £1 it owes within the next twelve months. A ratio below 1.0 is comparable to low blood pressure — the business cannot comfortably fund its immediate operations from its own liquid resources.


3. Symptoms Analysis

The financial statements reveal several symptoms of underlying weakness:

  • Balance-sheet insolvency: Net assets have been negative since at least 2021, and the deficit is widening. This is the most serious symptom, because it means the company could not settle all its debts even if every asset were realised.
  • Liquidity shock: With current assets of £929 against creditors of £1,654, the company lacks the cash or near-cash resources to meet obligations due within the next year.
  • Rapid creditor accumulation: Liabilities rose from £404 (2024) to £575 (2025) to £1,654 (2026). This trajectory suggests the business is funding its operations through unpaid bills or director-related funding rather than trading surpluses.
  • No asset cushion: There are no fixed assets (property, plant, equipment, or investments) to act as collateral or a reserve. All reported assets are current and modest.
  • Limited visibility: The director elected not to include a profit and loss account in the filed statements, so this assessment cannot comment on turnover, gross margin, or operating profitability. The balance sheet alone shows deterioration, but the underlying trading performance is opaque.

The company changed its name from Athena Defence Limited to Authentic Intelligence Global Limited on 15 December 2025. This may reflect a strategic pivot, but the financial statements do not yet show a strengthening balance sheet to support that transition.


4. Diagnosis

Overall condition: Balance-sheet insolvency with acute liquidity distress and elevated going-concern risk.

In medical terms, the company is presenting with severe hypotension (low liquidity) and negative equity (a deficit in its financial reserves). It is surviving on short-term credit rather than generating internal surpluses. The company remains active and its filings are up to date, which are positive signs of administrative health. However, the underlying financial condition is fragile. Without an injection of capital or a restructuring of creditor terms, the risk of creditor enforcement action increases.


5. Prognosis

The outlook is guarded to poor unless immediate steps are taken.

If the director or person with significant control introduces new funds, converts existing loans into equity, or secures creditor agreement to a repayment plan, the company could stabilise. If trading continues to generate losses while creditors remain unpaid, the trajectory points toward formal insolvency proceedings. The absence of a published profit and loss account makes it difficult to forecast whether the business model can return to profit, adding further uncertainty to the prognosis.


6. Recommendations

  1. Inject working capital urgently: The director or shareholders should consider a cash injection or convert outstanding director loans into equity to restore positive net assets.
  2. Engage creditors early: Contact the parties owed £1,654 to negotiate payment terms or a Time to Pay arrangement before enforcement action begins.
  3. Prepare a 13-week cash flow forecast: Model weekly inflows and outflows to identify the precise date by which new funding is required.
  4. Produce monthly management accounts: Since the profit and loss account is not publicly filed, internal monthly reporting is essential to monitor sales, costs, and profitability.
  5. Review the post-rebrand business model: Assess whether the shift from defence-related support to “authentic intelligence” services is generating sufficient billable work to cover overheads.
  6. Seek professional advice: Consult an accountant or insolvency practitioner to evaluate options, including a Company Voluntary Arrangement or other restructuring, if creditor pressure mounts.
  7. Maintain filing discipline: Continue to submit accounts and confirmation statements on time to avoid additional penalties and preserve credibility with stakeholders.

Perspective: Financial Health Diagnostician · Model: nvidia/nemotron-3.5-super-vl:free · Generated 7 November 2026